Literature DB >> 7686108

Differential activation and survival of basal forebrain neurons following infusions of excitatory amino acids: studies with the immediate early gene c-fos.

K J Page1, A Saha, B J Everitt.   

Abstract

These experiments investigated, by studying patterns of c-fos expression, the distribution of neurons activated or destroyed by the infusion into the basal forebrain of various excitatory amino acids at toxic and subtoxic doses. The results of experiment 1 showed that N-methyl-D-aspartic acid (NMDA), quisqualic acid and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) differentially increased the expression of c-fos in magnocellular cholinergic nucleus basalis, dorsal and ventral pallidal neurons. AMPA was the most, and NMDA the least, effective in inducing FOS in nucleus basalis magnocellularis (nbM) neurons, with quisqualic acid having an intermediate effect, whereas the reverse was true in terms of the induction of FOS in pallidal neurons. In experiment 2, it was demonstrated that, in animals with ibotenic acid-induced lesions of the basal forebrain that were targetted on the nbM, virtually no pallidal neurons could be visualized that expressed FOS following AMPA-induced excitation of the dorsal and ventral striatum. By contrast, in animals with AMPA-induced lesions of the nbM, excitation of the striatum was followed by the expression of FOS in many dorsal and ventral pallidal neurons. Thus, infusions of AMPA into the basal forebrain appears preferentially to activate or destroy, depending on the concentration infused, cholinergic nbM neurons, whereas ibotenic acid or NMDA preferentially destroys or activates neurons of the dorsal and ventral pallidum. These results provide novel and complementary information regarding the organization of the basal forebrain and allow a clearer understanding of the different behavioural consequences of NMDA agonist-induced and non-NMDA agonist-induced excito-toxic lesions of this area.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686108     DOI: 10.1007/bf00229357

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  40 in total

1.  Prefrontal cortical projections to the cholinergic neurons in the basal forebrain.

Authors:  R P Gaykema; R van Weeghel; L B Hersh; P G Luiten
Journal:  J Comp Neurol       Date:  1991-01-22       Impact factor: 3.215

Review 2.  The non-NMDA receptors: types, protein structure and molecular biology.

Authors:  E A Barnard; J M Henley
Journal:  Trends Pharmacol Sci       Date:  1990-12       Impact factor: 14.819

3.  Induction of c-fos-like protein in spinal cord neurons following sensory stimulation.

Authors:  S P Hunt; A Pini; G Evan
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

Review 4.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata.

Authors:  G F Alheid; L Heimer
Journal:  Neuroscience       Date:  1988-10       Impact factor: 3.590

5.  Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress.

Authors:  S Ceccatelli; M J Villar; M Goldstein; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Effect of cholinesterase inhibitors on Morris water task behavior following lesions of the nucleus basalis magnocellularis.

Authors:  C P Dokla; L J Thal
Journal:  Behav Neurosci       Date:  1988-12       Impact factor: 1.912

7.  Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats.

Authors:  S B Dunnett
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Ultrastructural evidence of amygdalofugal axons terminating on cholinergic cells of the rostral forebrain.

Authors:  L Záborszky; C Léránth; L Heimer
Journal:  Neurosci Lett       Date:  1984-12-21       Impact factor: 3.046

9.  Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats.

Authors:  S B Dunnett; I Q Whishaw; G H Jones; S T Bunch
Journal:  Neuroscience       Date:  1987-02       Impact factor: 3.590

10.  Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss.

Authors:  K J Page; B J Everitt; T W Robbins; H M Marston; L S Wilkinson
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

View more
  5 in total

Review 1.  Regulation of cortical acetylcholine release: insights from in vivo microdialysis studies.

Authors:  Jim R Fadel
Journal:  Behav Brain Res       Date:  2010-02-16       Impact factor: 3.332

2.  Effect of a thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test.

Authors:  T M Ballard; A J Hunter; G W Bennett
Journal:  Psychopharmacology (Berl)       Date:  1996-10       Impact factor: 4.530

3.  Transsynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neurons following AMPA-induced activation of the dorsal and ventral striatum.

Authors:  K J Page; B J Everitt
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

4.  c-Fos protein expression is increased in cholinergic neurons of the rodent basal forebrain during spontaneous and induced wakefulness.

Authors:  J T McKenna; J W Cordeira; B A Jeffrey; C P Ward; S Winston; R W McCarley; R E Strecker
Journal:  Brain Res Bull       Date:  2009-08-28       Impact factor: 4.077

5.  Basal forebrain lactate release and promotion of cortical arousal during prolonged waking is attenuated in aging.

Authors:  Henna-Kaisa Wigren; Kirsi-Marja Rytkönen; Tarja Porkka-Heiskanen
Journal:  J Neurosci       Date:  2009-09-16       Impact factor: 6.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.